Clearmind Medicine Inc. (NasdaqCM: CMND)
Health Care · Pharmaceuticals · CA
$6.61
+0.46% today · -97.8% 1Y
Clearmind Medicine Inc. (NasdaqCM: CMND) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.77M and employs 4 people.
Over the last twelve months the share price has lost 97.8%, trading between 1.76 and 384.00.
Tweenvest scores Clearmind Medicine Inc. across four factors: quality 34/100, value 63/100. Its strongest factor is value.
CMND price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.77M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -118.41
- Dividend yield
- —
- Beta (5Y)
- 0.46
- 52-week high
- $384.00
- 52-week low
- $1.76
- Avg volume (3M)
- —
- Shares outstanding
- 420.88K
- Employees
- 4
- Next earnings
- —
About Clearmind Medicine Inc.
Clearmind Medicine Inc. is a pre-clinical biopharmaceutical company dedicated to pioneering the development of novel psychedelic-based treatments. Their primary goal is to address a variety of mental health and addiction challenges that currently lack adequate solutions. The company's research targets conditions such as alcohol use disorder (including problematic binge drinking), various eating disorders (like binge eating), depression, and other compulsive or "binge" behaviors. Founded in 2017, the company initially operated under the name Cyntar Ventures Inc. before officially rebranding as Clearmind Medicine Inc. in March 2021. Its operations are headquartered in Vancouver, Canada.
- ISIN
- CA1850536006
- Founded
- 2017
- Listed since
- Nov 15, 2022
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Invion LimitedASX: IVX | $2.90M | AU$0.04 | -2.56% |
| Noveris Health Sciences Inc.CNSX: NVRS | $2.87M | CA$0.07 | -12.50% |
| Eastgate Biotech Corp.OTCPK: ETBI | $2.86M | $0.00 | -46.00% |
| SOHM, Inc.OTCPK: SHMN | $2.81M | $0.00 | +7.78% |
| Lasa Supergenerics LimitedNSEI: LASA | $2.77M | Rs5.32 | -5.00% |
| Nexalis Therapeutics LimitedASX: NX1 | $2.67M | AU$— | — |
| IM Cannabis Corp.NasdaqCM: IMCC | $2.60M | $1.42 | -10.13% |
| SciSparc Ltd.NasdaqCM: SPRC | $2.60M | $4.20 | -6.04% |
Figures last refreshed Oct 11, 2026.